You are on page 1of 6

1

1
(Midterm)
.
1. (stat)
2.
Abb.
Full word
Meaning
C/O
Complaining of

PC
Presenting complain

HPC
History of presenting compliant

PMH
Past medical history

DHx
Drug history

SH
Social history

FH
Family history

O/E
On examination

3. clinical intervention
take action detect
take action the must

4. DUE main concern


- std.
-
-
5. clinical intervention ( Ca supplement )

1. case Naranjos algorithm
( 7 probable)
2.
3. tracer agent
4. methods for monitoring ADRs
5. ( warfarin)
6. absorption
7. ()
8. pregnancy category ( 2
C )
A

1 3

2
1.

2. (
)
1 3

2
1. ( )

2.


(
)

()

: http://www.pha.nu.ac.th/practice/dis1/articles/PregCat.htm
9. ( all or none
)
10. ( cat X )
11. (
A
)
12. kenicturus ( sulfonamide )
13. glaucoma ( ADR anticholinergic
chlorpheniramine )
14. ( blocker )
15.
.
1. MAR
Medication administration record
2. DTP IESAC
Need for additional drug + Unnecessary drug ---> Indication

3
Low dose + wrong drug ---> Efficacy
High dose + ADRs ---> Safety
Compliance ---> Adherence
3. pharmacotherapy goal (cure control slow
prevent match )
.
1. 2
- ---> peak hour
pharm care
- ---> sensitive
ARVs OPD room

2. pharmaceutical care 2
- warfarin ---> therapeutic index
- 7 ---> underlying
disease drug
interaction
.
1. a medication therapy in patient care
d
preventive care, evidence base medicine, pharmaceutical care,
patient pharmacology assessment, identification and resolution of drug
related problems, developing care plan and goal of therapy follow up
evaluation
2.

1. smart approach ( budesonide + formotrol : symbicort)
2. ( )
3. ( Ca2+ )
4. ( 14 )
5. (
)
6. OSA ( CPAD)
7. asthma (chronic hyperresponsive, bronchoconstriction
reversible)

4
8. asthma (
)
9. ( LABA )
10. ( affinity local effect)
11. Definite risk factor asthma ()
12. LABA (formoterol)
13. allergic rhinitis asthma (
montelukast)
14. (bupropion)
15. (ask)
16. ( , COPD, )
17. ( counseling 5A)
18. COPD Asthma (COPD irreversible
asthma reversible, COPD asthma
)
19. COPD (VC FEV1 )
20. COPD (steroid)
21. Pleural effusion ()
22.

1. hypernatremia
2. LFT (cholestasis jaundice)
3. fish bone ()

4. part
*******************************************************

1
(Final)

1. ( )
2. (AST ALP)
3. ( INR )
4. lab (albumin)
5. ( clinical outcome)

5
6. part

1. ( ibuprofen naproxen)
2. ADRs ( )
3.
4. hypersensitivity 4 type ( )
5. ( erythema multiforme)
6. ( ADR )
7. medication error ADRs
8.

1. case ( part
peptic ulcer)
2. case definite risk factor (NSAIDs steroid
)
3. concern peptic ulcer ( 70 multiple NSAIDs)
4. case SBP (norfloxacin)
5. case ( non
selective blocker )
6. case ( H. piroli)
7. case (Hepatitis E)
8. case hepatitis B
( 6 )
9. case hepatitis B
( lamivudine)
10. case varices (
octreotide omeprazole )
11. case peptic ulcer (PPIs)
12. case underlying metabolic syndrome
()
13. case pancreatitis (imipenem)
14. case GI bleeding (omeprazole)
15. case cirrhosis (spironolactone)
16. ( )
17. course part

6

1. warfarin ( allopurinol)
2. allopurinol ( uric acid
)
3. SLE (malar rash)
4. methotrexate ( B6)
5. ()
6. NSAIDs OA ( PPIs)
7. 2 (lefunamide)
8. ( OA)
9.
allopurinol uricosuric agent
Uricosuric agent
Allopurinol

10. part
*******************************************************



Rx 72 ID 177
1/4/2557
17.51